Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1999 Jul;92(7):345–352. doi: 10.1177/014107689909200705

The evolution of tafenoquine--antimalarial for a new millennium?

W Peters 1
PMCID: PMC1297286  PMID: 10615272

Full text

PDF
345

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALVING A. S., JOHNSON C. F., TARLOV A. R., BREWER G. J., KELLERMEYER R. W., CARSON P. E. Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ. 1960;22:621–631. [PMC free article] [PubMed] [Google Scholar]
  2. ARNOLD J., ALVING A. S., CLAYMAN C. B. Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg. 1961 Jul;55:345–350. doi: 10.1016/0035-9203(61)90103-1. [DOI] [PubMed] [Google Scholar]
  3. ARNOLD J., ALVING A. S., HOCKWALD R. S., CLAYMAN C. B., DERN R. J., BEUTLER E., FLANAGAN C. L., JEFFERY G. M. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). J Lab Clin Med. 1955 Sep;46(3):391–397. [PubMed] [Google Scholar]
  4. Baird J. K., Basri H., Purnomo, Bangs M. J., Subianto B., Patchen L. C., Hoffman S. L. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1991 May;44(5):547–552. doi: 10.4269/ajtmh.1991.44.547. [DOI] [PubMed] [Google Scholar]
  5. Baird J. K., Basri H., Subianto B., Fryauff D. J., McElroy P. D., Leksana B., Richie T. L., Masbar S., Wignall F. S., Hoffman S. L. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J Infect Dis. 1995 Jun;171(6):1678–1682. doi: 10.1093/infdis/171.6.1678. [DOI] [PubMed] [Google Scholar]
  6. Baird J. K., Fryauff D. J., Basri H., Bangs M. J., Subianto B., Wiady I., Purnomo, Leksana B., Masbar S., Richie T. L. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1995 Jun;52(6):479–484. doi: 10.4269/ajtmh.1995.52.479. [DOI] [PubMed] [Google Scholar]
  7. Brueckner R. P., Coster T., Wesche D. L., Shmuklarsky M., Schuster B. G. Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial. Antimicrob Agents Chemother. 1998 May;42(5):1293–1294. doi: 10.1128/aac.42.5.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brueckner R. P., Lasseter K. C., Lin E. T., Schuster B. G. First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarial. Am J Trop Med Hyg. 1998 May;58(5):645–649. doi: 10.4269/ajtmh.1998.58.645. [DOI] [PubMed] [Google Scholar]
  9. Butcher G. A. Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol. 1997 Sep;27(9):975–987. doi: 10.1016/s0020-7519(97)00079-9. [DOI] [PubMed] [Google Scholar]
  10. Carson P. E., Hohl R., Nora M. V., Parkhurst G. W., Ahmad T., Scanlan S., Frischer H. Toxicology of the 8-aminoquinolines and genetic factors associated with their toxicity in man. Bull World Health Organ. 1981;59(3):427–437. [PMC free article] [PubMed] [Google Scholar]
  11. Clyde D. F. Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ. 1981;59(3):391–395. [PMC free article] [PubMed] [Google Scholar]
  12. Coleman R. E., Clavin A. M., Milhous W. K. Gametocytocidal and sporontocidal activity of antimalarials against Plasmodium berghei ANKA in ICR Mice and Anopheles stephensi mosquitoes. Am J Trop Med Hyg. 1992 Feb;46(2):169–182. doi: 10.4269/ajtmh.1992.46.169. [DOI] [PubMed] [Google Scholar]
  13. Collins W. E., Jeffery G. M. Primaquine resistance in Plasmodium vivax. Am J Trop Med Hyg. 1996 Sep;55(3):243–249. doi: 10.4269/ajtmh.1996.55.243. [DOI] [PubMed] [Google Scholar]
  14. Cooper R. D., Milhous W. K., Rieckmann K. H. The efficacy of WR238605 against the blood stages of a chloroquine resistant strain of Plasmodium vivax. Trans R Soc Trop Med Hyg. 1994 Nov-Dec;88(6):691–692. doi: 10.1016/0035-9203(94)90232-1. [DOI] [PubMed] [Google Scholar]
  15. Davidson D. E., Jr, Ager A. L., Brown J. L., Chapple F. E., Whitmire R. E., Rossan R. N. New tissue schizontocidal antimalarial drugs. Bull World Health Organ. 1981;59(3):463–479. [PMC free article] [PubMed] [Google Scholar]
  16. EDGCOMB J. H., ARNOLD J., YOUNT E. H., Jr, ALVING A. S., EICHELBERGER L., JEFFERY G. M., EYLES D., YOUNG M. D. Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc. 1950 Dec;9(4):285–292. [PubMed] [Google Scholar]
  17. Fryauff D. J., Baird J. K., Basri H., Sumawinata I., Purnomo, Richie T. L., Ohrt C. K., Mouzin E., Church C. J., Richards A. L. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet. 1995 Nov 4;346(8984):1190–1193. doi: 10.1016/s0140-6736(95)92898-7. [DOI] [PubMed] [Google Scholar]
  18. Galer B. B., Billenstien D. C. Ultrastructural development of the saccus vasculosus in rainbow trout (Salmo gairdneri). Z Zellforsch Mikrosk Anat. 1972;128(2):162–174. doi: 10.1007/BF00306896. [DOI] [PubMed] [Google Scholar]
  19. Obaldia N., 3rd, Rossan R. N., Cooper R. D., Kyle D. E., Nuzum E. O., Rieckmann K. H., Shanks G. D. WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys. Am J Trop Med Hyg. 1997 May;56(5):508–510. doi: 10.4269/ajtmh.1997.56.508. [DOI] [PubMed] [Google Scholar]
  20. Peters W., Robinson B. L., Milhous W. K. The chemotherapy of rodent malaria. LI. Studies on a new 8-aminoquinoline, WR 238,605. Ann Trop Med Parasitol. 1993 Dec;87(6):547–552. doi: 10.1080/00034983.1993.11812809. [DOI] [PubMed] [Google Scholar]
  21. Powell R. D., Brewer G. J. Effects of pyrimethamine, chlorguanide, and primaquine against exoerythrocytic forms of a strain of chloroquine-resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg. 1967 Nov;16(6):693–698. [PubMed] [Google Scholar]
  22. Pukrittayakamee S., Vanijanonta S., Chantra A., Clemens R., White N. J. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis. 1994 Apr;169(4):932–935. doi: 10.1093/infdis/169.4.932. [DOI] [PubMed] [Google Scholar]
  23. Rieckmann K. H., Davis D. R., Hutton D. C. Plasmodium vivax resistance to chloroquine? Lancet. 1989 Nov 18;2(8673):1183–1184. doi: 10.1016/s0140-6736(89)91792-3. [DOI] [PubMed] [Google Scholar]
  24. SCHMIDT L. H., GENTHER C. S. The antimalarial properties of 2, 4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, daraprim. J Pharmacol Exp Ther. 1953 Jan;107(1):61–91. [PubMed] [Google Scholar]
  25. Schuurkamp G. J., Spicer P. E., Kereu R. K., Bulungol P. K. A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report. Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):607–608. doi: 10.1016/0035-9203(89)90370-2. [DOI] [PubMed] [Google Scholar]
  26. Snow R. W., Craig M. H., Deichmann U., le Sueur D. A preliminary continental risk map for malaria mortality among African children. Parasitol Today. 1999 Mar;15(3):99–104. doi: 10.1016/s0169-4758(99)01395-2. [DOI] [PubMed] [Google Scholar]
  27. Terzian L. A., Stahler N., Dawkins A. T., Jr The sporogonous of Plasmodium vivax in Anopheles mosquitoes as a system for evaluating the prophylactic and curative capabilities of potential antimalarial compounds. Exp Parasitol. 1968 Aug;23(1):56–66. doi: 10.1016/0014-4894(68)90042-8. [DOI] [PubMed] [Google Scholar]
  28. Weiss W. R., Oloo A. J., Johnson A., Koech D., Hoffman S. L. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis. 1995 Jun;171(6):1569–1575. doi: 10.1093/infdis/171.6.1569. [DOI] [PubMed] [Google Scholar]
  29. Whitby M., Wood G., Veenendaal J. R., Rieckmann K. Chloroquine-resistant Plasmodium vivax. Lancet. 1989 Dec 9;2(8676):1395–1395. doi: 10.1016/s0140-6736(89)92002-3. [DOI] [PubMed] [Google Scholar]
  30. White N. J. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob Agents Chemother. 1997 Jul;41(7):1413–1422. doi: 10.1128/aac.41.7.1413. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES